Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

NCT06200155 ↗

Phase 2 Recruiting 30 enrolled M.D. Anderson Cancer Center Gateway for Cancer Research · collab

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

To learn about the feasibility, safety, and effects of psilocybin-assisted psychotherapy on depression and/or anxiety in participants who are being treated for advanced cancer.

Timeline

Start: 2024-04-16
Primary completion: 2026-12-31
Completion: 2026-12-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Psilocybin	Other / unclassified	25 mg	Oral

Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

Summary

Timeline

Drugs

Indications